Who we are
REGENXBIO is an exceptional place to work. You'll have the opportunity to collaborate with some of the best and the brightest people, touch amazing science, and be a part of extraordinary plans. Our core values: Trust, Accountability, Perseverance, and Innovation drive everything we do. We aim to bring these values to life every day with all that we do, and we believe that what we do matters - to patients, to their families, and to their communities.
The Opportunity:
As a Senior Medical Science Liaison based in the Midwest or West Coast, you will provide support for REGENXBIO Rare Disease pre-commercial clinical trials and scientific collaborations with a focus on our Duchenne Muscular Dystrophy program. This is an exciting opportunity for an innovative MSL with an entrepreneurial spirit who enjoys building networks, interacting with KOLs, conducting scientific exchange, and supporting scientific conferences.
What you'll be doing:
Support clinical trial recruitment and site outreach; communicate coordinated feedback to the Clinical Operations, Clinical Development, and Duchenne Core teams.Serve as the field-based Medical Affairs representative to establish and cultivate scientific relationships with KOLs in the Duchenne community.Develop a strong understanding of clinical practice as it relates to Duchenne. Participate in refining KOL mapping; develop and execute on a customer-centric tactical engagement plan to support Medical Affairs strategies.Gather and share scientific insights via scientific exchange to inform executable and innovative Medical Affairs strategies.Serve as a resource for addressing unsolicited medical questions about REGENXBIO’s trials and investigational products.Provide clinical expertise in the development, management, and maintenance of clinical and scientific communications, including educational materials, meeting presentations and FAQs. Attend medical conferences as MA representative: assist with congress strategy / planning, medical booth staffing, competitive intelligence / insights gathering, and generating meeting summaries.Support Patient Advocacy conferences and outreach as requested.As a field-based position, you must be able to travel 50-70% of the time.It is imperative that REGENXBIO employees embody our core values by working collaboratively, building strong relationships and using clear communication to meet shared objectives.
What we're looking for:
Master’s degree (MPH or equivalent) required. Doctorate level (MD, PharmD, PhD) preferred.Minimum of 3 years of rare disease clinical or therapeutic experience in neuromuscular diseases, and/ or gene therapy with primary emphasis on field based scientific exchange and/or clinical trial support.Superior communication, relationship building and interpersonal skills.Ability to assimilate new clinical data quickly.Proactive problem-solving skills.Project management and medical writing skills.Flexibility, resilience, and creativity/ innovation in their work Ability to organize and lead high level projects.Ability to proactively predict issues and solve problems.Ability to work collaboratively with cross-functional teams.
Why should you apply?
By joining REGENXBIO, you will have the opportunity to be a part of a growing company, with an incredible team, who is passionate about developing novel AAV gene therapies for patients in need.
We offer a comprehensive and competitive benefit & compensation package which includes market-competitive salaries, an annual bonus program, education assistance, retirement plan with employer match, stock options at all levels, summer hours and more! The estimated compensation range for this role is $170,000 to $230,000 annually. The actual salary offered to the final candidate depends on a number of factors such as relevant work experience, skills, education, and years of experience.
In addition, professional development is important to us. By joining our team, you’ll have the opportunity to be exposed to challenging projects and have access to development resources to help you grow personally and professionally.
